Nano Tech vs. Traditional Kratom Tablets: A Comparison
Share
A traditional kratom tablet is pressed from ground kratom leaf powder. A Nano Tech Mitragynine tablet, the 7Stax line, starts from extracted mitragynine and goes through a particle size reduction step before it is formed into a tablet. This post compares how the two are made, what each label tells you, and what the batch certificate of analysis (COA) can and cannot confirm.
This page makes no claim about what a tablet does once taken. The batch COA is the place to check what a tablet contains.
What a traditional kratom tablet is
A traditional kratom tablet is made by pressing finely ground kratom leaf powder, often mixed with a binding agent, into a solid tablet. Because the contents are whole leaf, the tablet carries the plant's natural mix of alkaloids in roughly the proportions found in that leaf.
What a Nano Tech Mitragynine tablet is
A Nano Tech Mitragynine tablet starts from a kratom extract rather than ground leaf, and its labeled active is mitragynine in a stated amount per tablet. Our explainer on what MIT tablets are and how they are labeled covers the format in more detail.
7Stax uses the name Nano Tech for a particle size reduction step in making these tablets. It is not an added ingredient or a second active, and our guide to how a kratom extract differs from plain leaf powder explains the starting material.
The label strengths in the line are explained in our guide to MIT tablet strengths, and the packs currently listed are on the MIT tablets collection page.
What nano means in manufacturing
Nano is the metric prefix for one billionth, so a nanometer is one billionth of a meter. The nanoscale conventionally covers particles roughly 1 to 100 nanometers across, though food and supplement contexts sometimes stretch it to several hundred nanometers.
Common techniques
- Nano-milling: grinds a solid in ball or bead mills to a far smaller particle size.
- High-shear homogenization: forces a liquid through a narrow gap at high pressure to break droplets into smaller ones.
- Ultrasonication: uses high-frequency sound waves in a liquid to break droplets or particles apart.
- Microfluidization: drives two streams of a mixture into each other at high pressure to make a fine emulsion.
- Solvent displacement: dissolves an ingredient, then adds a second liquid that makes it settle out as very fine particles.
What the process produces
Depending on the method, the result can be nanoparticles, nano-suspensions, nano-emulsions (very small oil and water droplets held by an emulsifier) or nano-liposomes. For a tablet, the reduced-size material is stabilized and then formed into the tablet.
What particle size changes, and what it does not
Reducing particle size changes physical properties a lab can measure. These include particle size distribution, how a powder disperses in liquid, physical stability, and appearance and texture.
The Nano Tech name does not, on its own, tell you how much mitragynine is in a tablet, whether a batch is free of contaminants, or where the product stands legally. The batch COA and the law answer those questions, not the manufacturing name.
Traditional and Nano Tech tablets side by side
| Attribute | Traditional kratom tablet | Nano Tech Mitragynine tablet |
|---|---|---|
| Starting material | Ground kratom leaf powder | Kratom extract |
| Labeled active | Whole leaf with its natural alkaloid mix | Mitragynine, in a stated amount per tablet |
| Manufacturing step | Powder pressed with a binder | Particle size reduction step, then formed into a tablet |
| What the COA should report | Alkaloid results for that leaf batch, plus contaminant screens | Mitragynine per tablet, 7-OH (and MGPI where listed), plus contaminant screens |
How to check a Nano Tech claim
- If a report lists a measured particle size, read it, because a number says more than the word nano on its own.
- Match the lot number on your pack to its report on the 7Stax lab results page.
- Read the mitragynine result against the label, then check the 7-OH result and the MGPI result if the report lists one.
- Read the contaminant screens and the test date, using our guide to reading a certificate of analysis.
Our post on why third-party testing matters more than brand claims explains why the lab report counts for more than any name on the front of a pack.
Federal status of the MIT line as of October 21, 2026
As of October 21, 2026, mitragynine (MIT) and kratom leaf are not federally scheduled, as stated in DEA's October 14, 2026 notice in the Federal Register. In that notice, DEA sets out its intent to temporarily place 7-hydroxymitragynine (7-OH) and mitragynine pseudoindoxyl (MGPI) in Schedule I.
The thresholds in DEA's notice can also catch a product sold as mitragynine. A solid product is caught if its 7-OH and MGPI content, alone or combined, is more than 1 mg per gram, or if the mass of mitragynine divided by the mass of 7-OH (or of 7-OH plus MGPI) is less than 100.
Either test is enough on its own, so under the same DEA notice each MIT product's position depends on its tested 7-OH content and its ratio, both read from the batch COA.
A worked example (illustration only)
These are made-up round numbers to show the arithmetic. They are not results for any 7Stax batch.
| Example tablet | Tablet weight | Mitragynine | 7-OH (no MGPI) | Ratio | 7-OH per gram | Outcome under the notice |
|---|---|---|---|---|---|---|
| A | 0.5 g | 100 mg | 0.4 mg | 100 divided by 0.4 = 250 | 0.8 mg | Outside both thresholds |
| B | 0.5 g | 100 mg | 0.8 mg | 100 divided by 0.8 = 125 | 1.6 mg | Caught by the per gram test alone |
Under DEA's threshold test, Example B would still be caught, because it has more than 1 mg of 7-OH per gram even though its ratio is above 100. If a COA reports MGPI, add it to the 7-OH figure for both tests.
According to DEA's notice of intent, the temporary order can be published on or after November 13, 2026, takes effect on publication and lasts two years, with a possible one-year extension. It is not yet in effect.
State rules as of October 21, 2026
As of October 21, 2026, some states restrict kratom products or 7-OH, and the federal notice states that federal action does not preempt stricter state law. These are the state rules we have checked:
- Ten states prohibit 7-OH, according to the state summary in DEA's notice: Alabama, Arkansas, Connecticut, Indiana, Kansas, Louisiana, Massachusetts, Tennessee, Vermont and Wisconsin.
- Arizona, Colorado, South Carolina and Texas limit 7-OH as a share of total alkaloids, according to Powers Health's summary of state emergency orders on kratom.
- Florida's June 22, 2026 emergency rule placed concentrated 7-OH and related compounds in Schedule I under state law, as Florida Phoenix reported on the emergency rule.
- Massachusetts has an emergency order that places kratom in Schedule I under state law, according to Boston 25 News coverage of the Massachusetts order.
- North Dakota's HB 1628 (September 4, 2026) bans synthetic kratom derivatives and regulates leaf, and state officials said kratom stays unavailable until rules are in place, as Valley News Live reported.
- Kentucky's HB 757 sets a sales ban, and Recording Law's summary of Kentucky kratom law reports a start date of July 1, 2027. A manufacturer has sued, as WBKO reported on the lawsuit, and counsel is confirming the details.
State rules change often. Check your own state's current law, and do not rely on this page alone.
Frequently asked questions
Is Nano Tech an extra ingredient?
No. Nano Tech is the 7Stax name for a particle size reduction step in manufacturing, not an added ingredient or a second active.
Does the word nano tell me how much mitragynine is in a tablet?
No. The label states the amount of mitragynine per tablet, and the batch COA reports what the lab measured. The manufacturing name describes how the tablet is made, not what it contains.
Does a COA show whether a product is legal in my state?
No. A COA reports what a lab measured in one batch. State rules change often, so check your own state's current law.
Sources
- Federal Register 2026-20943, DEA notice of intent on 7-OH and MGPI, October 14, 2026, accessed October 21, 2026.
- Powers Health, states enact emergency orders on kratom, August 14, 2026, accessed October 21, 2026.
- Florida Phoenix, Florida emergency rule on 7-OH related products, June 22, 2026, accessed October 21, 2026.
- Boston 25 News, Massachusetts emergency order on kratom sales, accessed October 21, 2026.
- Valley News Live, North Dakota kratom bill, September 4, 2026, accessed October 21, 2026.
- Recording Law, Kentucky kratom laws, accessed October 21, 2026.
- WBKO, manufacturer lawsuit over Kentucky House Bill 757, June 3, 2026, accessed October 21, 2026.